New eye implant aims to halt diabetic vision damage
NCT ID NCT07235085
Summary
This large, late-stage study is testing a tiny, slow-dissolving implant placed in the eye to see if it can safely stop or reverse damage from diabetic retinopathy. It will compare the new implant to a mock injection procedure in about 930 adults with moderate to severe non-proliferative diabetic retinopathy. The main goal is to see if the implant improves the severity of the eye disease over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cumberland Valley Retina Consultants
RECRUITINGHagerstown, Maryland, 21740, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.